Lummy(300006.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Lummy
300006.SZ
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. The company was founded in 1999 and is headquartered in Chongqing, China.
2.788 T
300006.SZMarket value -Rank by Market Cap -/-

Financial Score

21/05/2026 Update
D
PharmaceuticalsIndustry
Industry Ranking192/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-7.55%D
    • Profit Margin-17.90%D
    • Gross Margin55.01%B
  • Growth ScoreD
    • Revenue YoY-6.57%D
    • Net Profit YoY-40.14%D
    • Total Assets YoY-1.10%D
    • Net Assets YoY-6.06%D
  • Cash ScoreD
    • Cash Flow Margin-25.59%E
    • OCF YoY-6.57%D
  • Operating ScoreD
    • Turnover0.29D
  • Debt ScoreB
    • Gearing Ratio32.65%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Lummy: Product Nicorandil tablets intend to be selected for the 11th batch of national drug procurement

    Zhitong·
    SZ
    300006
    -5.83%
    Zhitong·
    SZ
    300006
    -5.83%

    Lummy Pharmaceuticals released its performance for the first three quarters, with a net loss attributable to the parent company of 45.9172 million yuan

    Zhitong·
    SZ
    300006
    -5.83%
    Zhitong·
    SZ
    300006
    -5.83%

    The pharmaceutical sector fluctuates and strengthens, ASK PHARM hits the limit up

    Zhitong·
    SZ
    002755
    +2.92%
    SZ
    300111
    -5.51%
    SZ
    300436
    +1.87%
    Zhitong·
    SZ
    002755
    +2.92%
    SZ
    300111
    -5.51%
    SZ
    300436
    +1.87%

    Lummy obtained two drug registration certificates

    Zhitong·
    SZ
    300006
    -5.83%
    Zhitong·
    SZ
    300006
    -5.83%

    Lummy: The equity structure of the indirect controlling shareholder is expected to change

    Zhitong·
    SZ
    300006
    -5.83%
    Zhitong·
    SZ
    300006
    -5.83%
    © 2026 Longbridge｜Disclaimer